Global Ganja Report

A judge for the US District Court for the Southern District of New York on Feb. 26 dismissed a lawsuit challenging the Schedule I classification for cannabis under the Controlled Substances Act. Judge Alvin Hellerstein granted the government's motion to dismiss because the plaintiffs failed to exhaust all administrative remedies prior to initiating the suit. The "exhaustion rule" requires "that parties exhaust prescribed administrative remedies before seeking relief from federal courts."

Medical marijuana advocates and bureaucrats from regulatory agencies around the world have both been awaiting a statement on the risks and benefits of cannabidiol (CBD) from the World Health Organization's Expert Committee on Drug Dependence (ECDD). Now the assessment on the non-psychoactive cannabinoid is in, and it is encouraging news for those who have been hoping for its removal from Schedule 1, the international designation for drugs with no therapeutic value but high potential for abuse.

Amid the legal ambiguities about the status of cannabidiol (CBD), authorities in one state that had cracked down on preparations of the salutary cannabinoid are now admitting that they themselves are confused. Weeks after Indiana State Excise Police declared products containing CBD oil to be illegal—and carrying out a raid on an Indianapolis-aread natural goods store to prove it—state officials say they don’t actually know if CBD oil products are illegal or not.

The number of drug-related offenses is "higher than any other heinous crime in Nepal and is increasing at an alarming rate," according a none-too-objective March 17 account in Kathmandu's The Himalayan newspaper. The article credulously regurgitates the claims of a new report from the country's Narcotics Control Bureau, breaking down crime figures since 2011. The total for drug offenses rises to around 1,800, while those for murder and rape remain in the hudreds, and abduction in the two-digit range. And what kinds of drugs are at issue here? We are luridly told that "cultivation of genetically selected strains have [sic] led to increase in cannabis harvests. As a result, cannabis cultivation is increasing even in the hilly areas, posing a grave threat to security, according to the report."

Rep. Tom Garrett (R-VA) on Feb. 27 announced the introduction of legislation aimed at decriminalizing cannabis at the federal level. The ambitiously named "Ending Federal Marijuana Prohibition Act of 2017" would actually take cannabis off the federal controlled substances list—leaving regulation up to the states, and essentually giving the herb the same status as alcohol and tobacco. The bill revives an effort frst launched in the Senate by Bernie Sanders in 2015.

Last month, when the DEA dashed activist hopes for a rescheduling of cannabis, it also issued another lesser-noted decision—to put the psychoactive herb kratom in the same Schedule I classification as pot, that for the most dangerous drugs with no medical use. Advocates have launched a White House petition against the kratom ban, and have already won the required 100,000 signatures to trigger an administration reponse. The DEA decision takes effect on Sept. 30, while the White House has 60 days to respond to the petition, under its own policy.

After much speculation that the US Drug Enforcement Agency (DEA) would reschedule cannabis this summer, the agency on Aug. 11 dashed petitioners' hopes, rejecting their request to remove its classification as a Schedule I dangerous drug. The DEA denied two separate requests by former state governors to re-classify cannabis as a Schedule II drug or lower. The agency stated (PDF) that the Department of Health and Human Services (HHS) has "concluded that marijuana has high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision." Tthe DEA did propose a new policy that would allow universities to apply to grow cannabis for research. Until now, the University of Mississippi had a monopoly on cultivation for study. (Jurist)

After nine years of Conservative rule, Canada's Liberal Party had a momentous election night on Oct. 19, gaining a majority of seats in Parliament and a new prime minister in Justin Trudeau. The handsome and charismatic son of Canada's most formative prime minister, Trudeau had worked as a school teacher in Vancouver before becoming a parliamentarian representing Quebec. He promised a new beginning in Canadian politics—and a break with the increasingly right-wing policies of his predecessor, Stephen Harper. It remains to be seen if he will able to follow through on his ambitious promises—including to legalize cannabis.